Hansa Biopharma to Participate in Three Upcoming Investor Conferences
LUND, Sweden, Aug. 21, 2019 /PRNewswire/ -- Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG-mediated diseases, announced today that the Company's management team will participate in the following upcoming investor conferences:
-- The Goldman Sachs Ninth Annual Biotech Symposium in London on Friday,
September 6, 2019.
-- The Morgan Stanley 17th Annual Global Healthcare Conference in New York
City, NY Tuesday, September 10, 2019, with a presentation at 1:30 PM
EST/ 19:30 CET on the same day.
-- The Bank of America Merrill Lynch Global Healthcare Conference 2019 in
London from Thursday, September 19, 2019 to Friday, September 20, 2019,
with a presentation at 14:45 CET on Friday September 20.
A live webcast of the Morgan Stanley presentation will be available on the Events & Webcast page of the Company's website, www.hansabiopharma.com. A replay of the presentation will be available approximately two hours after the event and will be available for two weeks following the presentation.
CONTACT:
Klaus Sindahl, Head of Investor Relations
Hansa Biopharma
Mobile: +46 (0) 709-298 269
E-mail: klaus.sindahl@hansabiopharma.com
Rolf Gulliksen, Head of Corporate Communications
Hansa Biopharma
Mobile: +46 (0) 733-328 634
E-mail: rolf.gulliksen@hansabiopharma.com
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/hansa-biopharma-ab/r/hansa-biopharma-to-participate-in-three-upcoming-investor-conferences,c2884759
The following files are available for download:
https://mb.cision.com/Main/1219/2884759/1092648.pdf Hansa Biopharma to participate
in three upcoming investor
conferences
View original content:http://www.prnewswire.com/news-releases/hansa-biopharma-to-participate-in-three-upcoming-investor-conferences-300904967.html
SOURCE Hansa Biopharma AB
